Weeklyoptionplays
Followers | 110 |
Posts | 4,456 |
Boards Moderated | 1 |
Alias Born | 10/11/2009 |
Twitter Profile: | Temporarily Unavailable |
Follow on Twitter: | Follow @ Temporarily Unavailable |
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Best thing to happen for VRNG investors is VRNG to accept any reasonable buy out offer or settlement from Google unless they have a back up buy out option from other Microsoft/Apple/Yahoo or any reasonable mid size company.
I hope this will not end bitter for many investors out there. If this works out in a modest settlement say 150M or 200M this could be life changing trade/investment for many investors, instead of saying No to low ball offer from GOOGLE and ending up with no money at all.
Any offer that can give VRNG POS $8-$12 is good enough instead of dreaming big settlement big POS increase to $35 or $70 or $140.if we can get atleast 100% gain from VRNG we can play other stocks in future and we may get many other opportunities as these. Hope investors dont loose their shirts on this one.
Hope something positive works out for investors in weekend and we gap up on monday morning. Lets all benefit from this one.
Google looses small amount say 150M, VRNG gets rich by 150M(very conservative) and shareholders gets 100% rise pos. all good everyone is happy. Happy ending to the story.
My Random Thoughts on VRNG
STEVEKIMLAW-SEEKINGALPHA
So far the information we are getting about VRNG in Seekingalpha is from one person steve. I looked at his past articles, he seems to have covered only VRNG so far if iam not wrong. He says a multi bullionaire has got VRNG and eversince he has beleived this stock has stuff.
My Question is from where he is getting the info. Does he have any special contacts within VRNG? Latest article about MILS where VRNG has significant edge is not covered yet by any other Analysts or sites.
I searched Google focused articles if vrng news is floating around, Ppl are talkinga abt 700M-1b+ potential loss and it does not affect Gooogle anyway. 1B is nothing for Google.
I think GOOGLE main problem is if they agree they have benefited from patent breach it will hurt its ego since google content based search engine/advs is main source of googles income.
For facesaving they will force for buy over or i am afraid they will try drag the trail for more time unless the judge forces the settlement.
I hope this will be the last dilution by VRNG before the settlement is finalized even if they did for the right reason, if google decides to drag things lets hope VRNG wont dilute another round? if it happens it will be difficult for people to keep going in VRNG and stay positive.
I wish Crmaer and his followers join the longs. Does he think small company like VRNG cant fight with big Gaint GOOGLE. I guess he will change tune if there is a rumor of possible buyout by apple or yahoo or microsoft. Best thing to happen for VRNG is possible buyout option from these companies. I hope that will get the GOOGLE SETTLEMENT ASAP.
next try we will get past 5 decisively and probably stay above 5 for rest of the day.
by now people have noticed this wont get any cheaper than 4.8
once we are in 5.10-5.2 people will try to get all cheapies around 5
already we touched 5 mark, another push we will be in 5.2
I was thinking other way once we get a big push in 4.90's we will be back in 5 territory if there is another news in afternoon about possible settlement more ppl will join. we will end higher.
i have never traded a option one thing i know is we can trade a option with only my money 40k.
i have options trading acct in etrade pls guide me/explain more pm me if possbile.
Below is call option for $8 with .35 (133.3%) up.
what i dont understand is how .35 uptick equates to 133.3%
VRINGO INC COM (VRNG)
5.25 +0.95 (+22.09%) Bid: 5.15 Ask: 5.16 Vol: 35,206,689
10/4/12 4:00:00 PM ET
Order Type
- -Buy OpenSell OpenBuy CloseSell Close Contracts
Type
- -CallPut Expiration
- -Oct 20 '12Nov 17 '12Feb 16 '13May 18 '13Jan 18 '14 Strike
- -0.51.01.52.02.53.03.54.04.55.05.56.07.08.09.010.011.08.0
- -0.51.01.52.02.53.03.54.04.55.05.56.07.08.09.010.011.0
Price Type
- -MarketLimitStopStop LimitTrailing Stop $ Price
Term
Good For The DayGood For 60 DaysFill or KillImmediate or Cancel All-or-none
VRNG Oct 20 '12 $8 Call
0.35 +0.20 (+133.33%)
You have entered an invalid symbol.
Would you like to do a symbol search?
Bid (Size)
0.25 (448) Ask (Size)
0.35 (286) Volume
3,667 Open Interest
1,797
Closing Price 10/4/12 3:54
all pls respond to post# 5701 whats your take abt my gamble.
I have put 80k today in VRNG out of which 40k is margin money. Is it worth to take chances with 40k which is not my money. I have backup money which i can liquidate from some other avenues incase margin calls kick in worst case vrng bad outcome.
Is this the 90% safe 10% risky trade?
what you guys suggest, ofcourse tomorrow action will give more insights. I can flip and try to enter at lower price if goes that way and we see 20% + move. is it worth taking risk riding on 40k margin money into weekend? usually i take risks in my 3x etf/etn trades i have seen 10% up and 10% down says on my 3x etfs/etns
when compared to those 3x vrng is looking far better one for me.
lets see how it ends up.
the longer the better, price will be reaching new highs in anticipation of settlement news and competition from others.
MMRF
1B in settlement will account to $30 pos?
VRINGO INC COM VRNG: NYSE MKT LLC
Technology : Software & Programming
SnapshotChartsNewsOptions ChainsAnalyst ResearchFundamentalsEarningsInsider Activity Last Price Today’s Change Bid (Size) Ask (Size) Day’s Range Volume
5.25 +0.95 (+22.09%) 0.000 x0 0.000 x0 4.32 - 5.55 35,206,689
NYSE MKT LLC Real Time Quote Last Trade as of 4:00 PM ET 10/4/12 .Key StatisticsBalance SheetIncome StatementCash FlowSEC Filings
KEY STATISTICSIndustry Range: Low High Mouseover quintile for more detail Reuters Investment Profile Report
Shareholder Equity
Shares Outstanding 58.2 M
Institutional Ownership 4.04%
Number of Floating Shares 46.9 M
Short Interest as % of Float 15.84
Call Options Interest for $7 and $8 going Up.
CALLS OCT 20 '12 PUTS
Trade Quote Open
Interest Volume Net Change Last Bid Ask Strike
Price Bid Ask Last Net Change Volume Open
Interest Quote Trade
Trade Details 3,478 1,719 0.60 1.45 1.40 1.55 4.00 0.25 0.35 0.35 -0.30 995 940 Details Trade
Trade Details 1,585 1,845 0.50 1.20 1.15 1.25 4.50 0.50 0.60 0.55 -0.50 974 195 Details Trade
Trade Details 5,698 7,303 0.40 1.00 0.90 1.00 5.00 0.75 0.90 0.85 -1.35 1,141 143 Details Trade
Trade Details 2,182 2,611 0.35 0.75 0.70 0.80 5.50 1.10 1.20 1.10 -1.38 94 134 Details Trade
Trade Details 3,495 7,765 0.35 0.70 0.65 0.70 6.00 1.45 1.60 1.50 1.50 574 0 Details Trade
Trade Details 1,038 2,546 0.25 0.50 0.40 0.50 7.00 2.20 2.40 0.00 0.00 0 0 Details Trade
Trade Details 1,797 3,667 0.20 0.35 0.25 0.35 8.00 3.10 3.30 3.10 3.10 2 0 Details Trade
hope fully i get some 10grand on this if this goes to $6 plus.
order executed at 5.3 when i saw 5.26 in my streaming ask/bid
got back at 5.3 wow lets get back to 5.4
weeeeeeeee
sold fir $2400 profit.
again trying to enter at 5.3
whats the probability for the price going less than $5. If Google buys VRNG people are saying anywhere between $8-$45.
but for some reason if this does not go well for VRNG what are chances we see $3 where it was before the news?
I will be happy for $1 pos rise to $6.25
do we have gap up chances to $6 tomorrow??
got in at $5.25@14.5k shares. Hope i will make some $$$ with this.
already late to enter vrng or do we have chance for another 10-20% up?
AEZS Pos will open $3+. next week will be interesting if the slide continues from $3 to some $2.5
beacaz very few stocks go up after consolidation or reverse split.
yeap water disappeared in the woods
680's coming tomorrow.
750's our way if mini ipad launch is confirmed by Oct10th.
We have earnings on Oct 17th.
Lot of good catalysts our way.
show me some 680's tomorrow. Go AAPL
its apple stock boss lets see. we open 665 tomorrow and hit 680 by afternoon. ill take 1 grand by noon.
Earnings on Oct 5th.
any idea abt quarter results on oct 3 can we expect some 2-3% pop
tht would be real nice.
got 110 shares since then down $14, hoping for 690's by eow.
looking for .60 for a quick 10 cents pop.
what are catlayts in Nov/Dec for AEZS. I got 52k shares at .65 and sold at .75 today morning.
I am looking for good entry point for my 2nd AEZS trade. may be higher .50's
i played HEB in 2009 and lost my money. Is this good time to get back some? i will keep an eye on this.
Volatility: High
Low Average High
Technical Evaluation: BULLISH
Since August, 2012, the technical indicators for
AEZS have been BULLISH.
Relative Strength Rank: Strong
97
1 Lowest Highest 99Our positive fundamental outlook for the
biotechnology sub-industry for the next 12 months
reflects favorable prospects for novel drug
approvals. In 2011, the U.S. FDA approved 30 new
drugs, compared to 21 in 2010, including new
approaches to managing such diseases as
auto-immune disorder lupus and chronic hepatitis C
virus. In the first half of 2012, the FDA approved 14
such drugs, including new therapies for respiratory
disease cystic fibrosis and advanced prostate
cancer well ahead of planned review dates.We see
improving approval trends easing an overhang
stemming from FDA's inconsistency in making
decisions and in a timely fashion.
We expect the favorable M&A (mergers and
acquisitions) climate to continue, boosted by the
closing of two deals in August 2012 involving
prominent biotech names.We see large
pharmaceutical firms needing to offset lost
revenues from expiring drug patents and large
biotechs aiming to bolster their drug pipelines amid
maturing products and declining industry R&D
productivity trends.We also see large cap biotechs
increasingly generating cash flows to support larger
acquisitions. Of note, industry bellwether Amgen in
2011 became the first biotech company to initiate a
regular dividend.
In June 2012, the U.S. Supreme Court upheld the
health care reform law, including establishment of
an FDA infrastructure to govern "biosimilar" drug
approvals and the granting of a 12-year exclusivity
to branded drugmakers. Although we do not expect
"biosimilars" to reach the market for several years,
we see co-development partnering activity among
biotech and generics companies picking up. Once
they are marketed, we expect clinical and
manufacturing costs for biosimilar drugs to result in
more modest price discounts and higher retained
market share for branded drugs than seen in the
pharmaceutical industry.
Longer term, we expect wider adoption of biomarker
research and genetic-targeted clinical studies to
help shorten development times, and we see intense
competition in primary growth areas, led by cancer.
We recommend that investors concentrate core
holdings on established, profitable companies with
pipeline growth prospects, as smaller biotechs tend
to be more volatile.We would seek companies with
at least two years of operating capital and multiple
pipeline value drivers, as those relying on a single
value driver typically suffer significant share price
declines on an unfavorable outcome.
Year to date through September 7, the S&P Biotech
Index rose 36.6%, versus a 14.3% gain for the S&P
1500 Composite Index. In 2011, the sub-industry
index rose 20.0%, versus a 0.3% decline for the S&P
1500.
good volume today
Iphone 5S is durable too..
Apple 5S sold out every where. More Apple 5S news in coming week.
Hope we will not go backward again. if 3.20 is cleared we can form a nice base over 3.
some very nice gains with BAC this week.
BAC 9.35 open IMO
BAC 9.20 premarket
Hopefully bernanke wont speak till noon by tht time BAC will touch 9.5 IMO.
it depends on bernanke if BAC can touch 10 in coming days.
if QE3 is announced BAC will be 1 of few stocks to benefit. may be 12 looks good in short term if QE3 is there.